Delivra, Inc.   Report issue

For profit Phase 3
Founded: Hamilton ON Canada (2007)
Status: Acquired by Harvest One Cannabis Inc. (2019)

Organization Overview

First Clinical Trial
2016
NCT02960425
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Delivra, Inc.

Active Ingredients

Drugs in Phase 3 Trials (1)

creatine (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Muscle Weakness (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 1
  • # of Trial APIs: 1